These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 22826398)

  • 1. Atypical metastases from prostate cancer: 10-year experience at a single institution.
    Vinjamoori AH; Jagannathan JP; Shinagare AB; Taplin ME; Oh WK; Van den Abbeele AD; Ramaiya NH
    AJR Am J Roentgenol; 2012 Aug; 199(2):367-72. PubMed ID: 22826398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pattern and Distribution of Distant Metastases in Anaplastic Prostate Carcinoma: A Single-Institute Experience With 101 Patients.
    Ganeshan D; Aparicio AM; Morani A; Kundra V
    AJR Am J Roentgenol; 2017 Aug; 209(2):327-332. PubMed ID: 28590819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer progression in the presence of undetectable or low serum prostate-specific antigen level.
    Leibovici D; Spiess PE; Agarwal PK; Tu SM; Pettaway CA; Hitzhusen K; Millikan RE; Pisters LL
    Cancer; 2007 Jan; 109(2):198-204. PubMed ID: 17171704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
    Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
    Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single-center retrospective review of metastatic prostate cancer on PSMA position emission tomography/computed tomography: Beyond lymph nodes and bones.
    De Jesus GNC; Pereira V; Karak P; Shearier E
    Prostate; 2025 Jan; 85(1):13-20. PubMed ID: 39295117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic pattern of bladder cancer: correlation with the characteristics of the primary tumor.
    Shinagare AB; Ramaiya NH; Jagannathan JP; Fennessy FM; Taplin ME; Van den Abbeele AD
    AJR Am J Roentgenol; 2011 Jan; 196(1):117-22. PubMed ID: 21178055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Small cell and anaplastic prostate cancer: correlation between CT findings and prostate-specific antigen level.
    Schwartz LH; LaTrenta LR; Bonaccio E; Kelly WK; Scher HI; Panicek DM
    Radiology; 1998 Sep; 208(3):735-8. PubMed ID: 9722854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Features of unusual metastases from prostate cancer.
    Long MA; Husband JE
    Br J Radiol; 1999 Oct; 72(862):933-41. PubMed ID: 10673942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate specific antigen level and Gleason score in predicting the stage of newly diagnosed prostate cancer.
    Spencer JA; Chng WJ; Hudson E; Boon AP; Whelan P
    Br J Radiol; 1998 Nov; 71(851):1130-5. PubMed ID: 10434906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging yield from 133 consecutive patients with prostate cancer and low trigger PSA from a single institution.
    Shinagare AB; Keraliya A; Somarouthu B; Tirumani SH; Ramaiya NH; Kantoff PW
    Clin Radiol; 2016 Mar; 71(3):e143-9. PubMed ID: 26767544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoreductive radical prostatectomy in patients with prostate cancer and low volume skeletal metastases: results of a feasibility and case-control study.
    Heidenreich A; Pfister D; Porres D
    J Urol; 2015 Mar; 193(3):832-8. PubMed ID: 25254935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer and radiation therapy--the message conveyed by serum prostate-specific antigen.
    Zagars GK; Pollack A; von Eschenbach AC
    Int J Radiat Oncol Biol Phys; 1995 Aug; 33(1):23-35. PubMed ID: 7543892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-grade prostatic intraepithelial neoplasia with adjacent small atypical glands on prostate biopsy.
    Kronz JD; Shaikh AA; Epstein JI
    Hum Pathol; 2001 Apr; 32(4):389-95. PubMed ID: 11331955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting lymph nodes metastasis in prostate cancer through extended vs. standard laparoscopic pelvic lymphadenectomy.
    Arenas LF; Füllhase C; Boemans P; Fichtner J
    Aktuelle Urol; 2010 Jan; 41 Suppl 1():S10-4. PubMed ID: 20094944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
    Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
    BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D; Goppelt M; Dorn R; Wawroschek F; Harzmann R
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.
    Potters L; Purrazzella R; Brustein S; Fearn P; Leibel SA; Kattan MW
    Cancer; 2002 Oct; 95(7):1451-6. PubMed ID: 12237913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perineural invasion and seminal vesicle involvement predict pelvic lymph node metastasis in men with localized carcinoma of the prostate.
    Stone NN; Stock RG; Parikh D; Yeghiayan P; Unger P
    J Urol; 1998 Nov; 160(5):1722-6. PubMed ID: 9783940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
    Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
    Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between prostate-specific antigen and the presence of measurable soft tissue metastases in hormone-refractory prostate cancer.
    Figg WD; Ammerman K; Patronas N; Steinberg SM; Walls RG; Dawson N; Reed E; Sartor O
    Cancer Invest; 1996; 14(6):513-7. PubMed ID: 8951355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.